Saturday, February, 23, 2019 01:57:20
Page125.org
Menu
  • Medical Devices
  • Biotechnology
  • Healthcare IT
  • Pharmaceuticals
Trending News:
  • Reata announces positive results from bardoxolone phase 2 study
  • Diploid & Genomenon team up to advance rare disease diagnostics
  • FDA permits Priority Review for Roche’s drug Polatuzumab Vedotin
  • Glenmark Pharma seeks USFDA approval for generic skin treatment foam
Home
Contact US

Contact US

Physical Address

2151 Salvio St,
Ste A2-536,
Concord, CA 94520
e-Mail: [email protected]

Contact for News

Ojaswita Kutepatil[email protected] https://twitter.com/ojaswita_k
Shikha Sinha[email protected] https://twitter.com/shikhas999/
Editor[email protected]

Latest News

Reata announces positive results from bardoxolone phase 2 study

Reata announces positive results from bardoxolone phase 2 study

Diploid & Genomenon team up to advance rare disease diagnostics

Diploid & Genomenon team up to advance rare disease diagnostics

FDA permits Priority Review for Roche’s drug Polatuzumab Vedotin

FDA permits Priority Review for Roche’s drug Polatuzumab Vedotin

Glenmark Pharma seeks USFDA approval for generic skin treatment foam

Glenmark Pharma seeks USFDA approval for generic skin treatment foam

Innovent, Chipscreen Biosciences team up on colorectal cancer therapy

Innovent, Chipscreen Biosciences team up on colorectal cancer therapy

AbCellera to sign multi-target partnership deal with Novartis

AbCellera to sign multi-target partnership deal with Novartis

  • About Us
  • Privacy Policy
  • Editorial Policy
  • Our Team
  • Contact US

Physical Address

2151 Salvio St,
Ste A2-536,
Concord, CA 94520
e-Mail: [email protected]
Page125.org Copyright © 2019.